2025-07-31 - Analysis Report
Okay, here's an analysis of Albemarle Corp (ALB) based on the provided data, presented in a report format.

## Albemarle Corp (ALB) Stock Analysis

**Company Overview:** Albemarle Corp is a specialty chemicals company with leading positions in lithium, bromine, and catalysts.

### 1. Performance vs. S&P 500 (VOO)

**Key Metrics:**

*   **ALB Cumulative Return:** 17.24%
*   **VOO Cumulative Return:** 98.84%
*   **Absolute Deviation:** -80.5
*   **Relative Deviation:** 2.4 (Indicates ALB's performance is near the lowest end of its historical range relative to VOO)

**Analysis:**

ALB has significantly underperformed the S&P 500 (VOO) over the period analyzed. The negative deviation highlights this underperformance. The relative deviation of 2.4 suggests that Albemarle's underperformance, relative to its historical deviations from VOO, is currently near its worst levels.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD   | Alpha   | Beta  | Cap(B) |
|------------|---------|-------|---------|-------|--------|
| 2015-2017  | 99.0%   | 8.1%  | 70.0%   | 0.0   | 15.1   |
| 2016-2018  | 13.0%   | 58.0% | -5.0%   | 0.0   | 9.1    |
| 2017-2019  | -44.0%  | 58.0% | -74.0%  | -0.0  | 8.6    |
| 2018-2020  | 101.0%  | 62.9% | 81.0%   | 0.6   | 17.4   |
| 2019-2021  | 268.0%  | 62.9% | 220.0%  | 0.6   | 27.5   |
| 2020-2022  | 239.0%  | 75.6% | 237.0%  | 0.8   | 25.5   |
| 2021-2023  | -53.0%  | 77.5% | -71.0%  | 0.6   | 17.0   |
| 2022-2024  | -200.0% | 77.5% | -225.0% | 0.7   | 10.1   |
| 2023-2025  | -331.0% | 77.5% | -382.0% | 3.0   | 8.1    |

**Analysis:**

*   **CAGR:** The Compounded Annual Growth Rate (CAGR) shows significant volatility across the years. Recent periods (2021-2025) show substantial negative growth.
*   **MDD:** Maximum Drawdown (MDD) indicates the largest peak-to-trough decline during the period.  The MDD is high, consistently above 50%, indicating significant risk.
*   **Alpha:** Alpha measures the stock's performance relative to the market (S&P 500). Recent Alpha values are extremely negative, meaning Albemarle has significantly underperformed the market.
*   **Beta:** Beta measures the stock's volatility relative to the market. Beta values are generally low, implying that the stock is less volatile than the market, but the recent period (2023-2025) shows a very high Beta of 3.0, suggesting increased volatility and a strong correlation with market movements.
*   **Cap(B):** Market capitalization varied over time.

### 2. Recent Stock Price Trends

**Key Metrics:**

*   **Current Price:** 68.89
*   **Previous Close:** 71.6
*   **Change:** -3.78
*   **5-day Moving Average:** 76.64
*   **20-day Moving Average:** 73.74
*   **60-day Moving Average:** 64.36

**Analysis:**

The stock price has recently decreased significantly (change of -3.78). The 5-day and 20-day moving averages are above the current price, indicating a short-term downtrend. The 60-day moving average is below the 20-day moving average, suggesting a longer-term uptrend may be weakening.

### 3. Market Risk Indicators & Expected Return

**Key Metrics:**

*   **Market Risk Indicator (MRI):** 0.3349 (Low Risk)
*   **RSI:** 43.94
*   **PPO:** -1.35
*   **Hybrid Signal:** Sell 70% of holdings (Cash Ratio: 70% on 2025-07-29)
*   **Delta_Previous_Relative_Divergence:** -5.4 (Negative: Short-term decline)
*   **Expected Return:** 4803.1% (Long-term, relative to S&P 500)

**Analysis:**

*   **MRI:** The Market Risk Indicator suggests low risk, although this seems contradictory given other indicators.
*   **RSI:** The Relative Strength Index (RSI) is at 43.94, suggesting the stock is neither overbought nor oversold, but trending towards oversold territory.
*   **PPO:** The Percentage Price Oscillator (PPO) is negative, indicating a bearish trend.
*   **Hybrid Signal:**  The hybrid signal strongly recommends selling a significant portion (70%) of ALB holdings and increasing the cash position. This is a significant bearish signal. The MRI caveat is worth noting, but the sell signal is dominant.
*   **Delta_Previous_Relative_Divergence:** The negative change in relative divergence indicates a short-term decline in performance compared to the S&P 500.
*   **Expected Return:** The extremely high expected return (4803.1%) should be viewed with skepticism. It suggests significant potential outperformance relative to the S&P 500 in the long term if making regular investments, but this contradicts many of the other bearish signals. Such a high number warrants further investigation and validation.
*   **Price Change:** The price change of -3.78 indicates a notable downward movement, likely contributing to the negative sentiment.

### 4. Recent News & Significant Events

*   **2025-07-27:** News indicates major business developments, regulatory changes, or market events impacting Albemarle.
*   **2025-07-29:** Analysts are discussing recent performance and outlook in the context of industry trends and global economic factors.
*   **2025-07-31:** Stock volatility is noted, influenced by recent news, earnings reports, or executive actions.
*   **2025-07-30:** Market experts highlight both risks and opportunities, advising monitoring of recent news and company announcements.

**Analysis:**

The news suggests the company is facing significant events causing volatility and scrutiny from analysts.  The advice to monitor recent news and announcements indicates potential uncertainty and the need for caution.

### 5. Recent Earnings Analysis

| 날짜       | EPS   | 매출        |
|------------|-------|-------------|
| 2025-04-30 | 0     | 1.08 B$     |
| 2024-11-06 | -9.45 | 1.35 B$     |
| 2024-07-31 | -1.96 | 1.43 B$     |
| 2024-05-01 | -0.08 | 1.36 B$     |
| 2025-04-30 | -0.08 | 1.36 B$     |

**Analysis:**

The EPS (Earnings Per Share) values are concerning.  Recent quarters show negative EPS, indicating losses. While revenue has been above $1 billion, the lack of profitability is a significant red flag.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue   | Profit Margin |
|--------------|-----------|---------------|
| 2025-03-31   | $1.08B    | 14.51%       |
| 2024-12-31   | $1.23B    | 11.22%       |
| 2024-09-30   | $1.35B    | -7.68%        |
| 2024-06-30   | $1.43B    | -0.74%        |
| 2024-03-31   | $1.36B    | 2.86%         |

**Capital and Profitability:**

| Quarter      | Equity   | ROE      |
|--------------|----------|----------|
| 2025-03-31   | $10.03B  | 0.41%    |
| 2024-12-31   | $9.96B   | 0.76%    |
| 2024-09-30   | $10.24B  | -10.44%   |
| 2024-06-30   | $11.22B  | -1.68%    |
| 2024-03-31   | $11.53B  | 0.02%    |

**Analysis:**

*   **Revenue and Profitability:**  While revenue has been strong, the profit margins have fluctuated and turned negative in recent quarters, confirming the earnings concerns.
*   **Capital and Profitability:** Equity has decreased, and Return on Equity (ROE) is negative for some quarters, indicating poor capital utilization and returns for shareholders.

### 7. Summary and Conclusion

Based on the data provided, Albemarle Corp (ALB) is currently facing significant challenges. Key concerns include:

*   **Underperformance:**  Significant underperformance compared to the S&P 500.
*   **Negative Earnings:** Recent negative EPS and declining profitability.
*   **Bearish Signals:**  Strong "Sell" signal from the hybrid indicator, negative PPO, and recent price decline.
*   **Volatility:** News indicates significant volatility and uncertainty surrounding the company.

**Recommendation:**

While the extremely high expected return figure might be enticing, it is outweighed by the numerous bearish signals and concerning financial data. The recommendation from the hybrid signal is to significantly reduce holdings. Investors should exercise caution and closely monitor company news and financial performance before making any investment decisions. Further investigation into the reasons behind the negative earnings and underperformance is strongly advised.

**Disclaimer:** This analysis is based solely on the provided data and should not be considered financial advice.
